HOME

Division Faculty

Philip J. DiSaia, MD
Division Director and Professor

Michael L. Berman, MD
Professor

Wendy Brewster, MD, PhD
Associate Professor

Robert A. Burger, MD
Associate Professor of Clinical Obstetrics and Gynecology

Alberto Manetta, MD
Professor

Bradley J. Monk, MD
Associate Professor


Fellowship Program


Links

University of California, Irvine, Health Sciences

UCI School of Medicine

UCI Medical Center

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Division of Gynecologic Oncology

Wendy R. Brewster, MD, PhD

Associate Professor
Division of Gynecologic Oncology
E-mail: wrbrewst@uci.edu
Make an Appointment


Clinical Interests

Dr. Brewster’s clinical interests are in the areas of gynecologic oncology and cancer epidemiology. She has demonstrated expertise in the full array of operative procedures including radical pelvic, intestinal and urological procedures.


Research Interests

Dr. Brewster is a Co-Investigator for an NCI funded grant to implement an effective single-visit cervical cancer screening program. Additionally, Dr. Brewster is a Co-Principal Investigator of the largest series of breast cancer survivors receiving hormone replacement therapy. Other research interests include population-based investigations to identify women at risk for breast or ovarian cancer and to determine the risk factors for the development of multiple primary reproductive tract malignancies.

Education

Degree Major University Year
PhD
Epidemiology
University of California, Irvine
2000
Fellowship
Gynecologic
Oncology
University of California, Irvine
1999
Residency
Obstetrics and Gynecology
Harbor-UCLA Medical Center
1995
M.D.
Medicine
University of California,
Los Angeles
1991
B.A.
Mathematics
Rutgers University
1987


Selected Publications

Book Chapters
Berman ML, DiSaia PJ, Brewster WR. Pelvic Malignancies, Gestational Trophoblastic Neoplasia, and Nonpelvic Malignancies, Maternal Fetal Medicine. Third edition. Editors, R.K. Creasy and R. Resnik. Philadelphia, W.B. Saunders Co., Dec, 1998.

Brewster WR, DiSaia PJ. Cancer in Pregnancy, Practical Strategies and Treatment in Obstetrics and Gynecology. First Edition. W.B. Saunders Co., May 1999.

Brewster WR, DiSaia PJ. Estrogen replacement therapy for breast cancer survivors. Breast Cancer, Atlas of Clinical Oncology. First edition. Editors Winchester DJ and Winchester DP. Publisher B.C. Decker, Feb 2000.

Brewster WR, DiSaia PJ. HRT in Breast Cancer Survivors. Ransom S, Dombrowski M,Evans M, Ginsburg K, ed. In: Contemporary Therapy in Obstetrics and Gynecology Issues and Controversies. W.B. Saunders, 2002.

Journal Articles, Peer Reviewed
Yamada SD, Anton D, Brewster WR, Kohler MF, Monk BJ, Burger RA. Pathologic variables and adjuvant therapy as predictors of recurrence and survival in surgically staged malignant mixed mesodermal tumors of the uterus. Cancer 88:2782-6, 2000.

DiSaia PJ, Brewster WR. Hormone replacement therapy (HRT) in postmenopausal women. Am J of Ob Gyn, 183 (2):517, Aug 2000.

Garite TJ, Weeks J, Peters-Phair K, Pattillo C, Brewster WR. A randomized controlled trial of the effect of increased intravenous hydration on the course of labor in nulliparas. American Joural of Obstetrics & Gynecology 2000;183:1544-8

DiSaia PJ, Brewster WR, Ziogas A, Anton-Culver H. Breast cancer survival and hormone replacement therapy. American Journal of Clinical Oncology 2000;23(6);541-55.

Brewster, WR, Ziogas A, Monk BJ, DiSaia, PJ, Anton-Culver H, and Berman ML. An intent to treat analysis of US women with stage IB/IIA cervical cancer: Radiotherapy versus surgery 1988-1995. Obstetrics & Gynecology 2001;97:248-546.

Theurer CP, Wagner JL, Taylor TH, Brewster, WR, Tran D, McLaren CE, Anon-Culver H. Racial and ethnic colorectal patterns affect the cost-effectiveness of colorectal screening in the United States. Gatroenterology 2001;120:848-856.

Keefe KA, Schell MF, Brewer C, McHale MT, Brewster WR, Chapman JA, rose GS, McMeekin DS, Lagerberg W, Peng YM, Wilxzynski SP, Anton-Culver H, Meyskens, FL, Merman ML. A randomized, double blind, phase III trial using oral beta-carotene supplementation for women with high grade cervical intraepithelial neoplasia. Cancer Epidemiology, Biomarkers & Prevention 10(10):1029-1035, 2001.